Novartis, Google and Stevanato all contributed to a series C round for the biotherapeutics company, which has also signed a collaboration deal with Novartis.

Colorado diagnostics spin-out MBio raises $6.3m in series B.

Calimmune, which is developing gene therapy treatments for HIV and AIDS, has raised cash in a round led by an unnamed pharmaceutical company.

Novo-backed medical device maker Si-Bone has closed a $21m round that will fund its expansion in multiple geographic markets.

Ambrx, an oncology company that had raised more than $200m, is being acquired by a consortium including Fosun Pharmaceutical and WuXi PharmaTech.